An Analysis of Serum MiR-122 and MiR-17 Expressions in Patients with Hepatitis B Liver Fibrosis and Their Predictive Effects on Liver Fibrosis

An Analysis of Serum MiR-122 and MiR-17 Expressions in Patients with Hepatitis B Liver Fibrosis and Their Predictive Effects on Liver Fibrosis

LI Huazhong, CAI Duxiong, CHEN Caili

PDF(1138 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1138 KB)

Labeled Immunoassays and Clinical Medicine ›› 2021, Vol. 28 ›› Issue (9) : 1542-1548. DOI: 10.11748/bjmy.issn.1006-1703.2021.09.020

Clinical Investigation

An Analysis of Serum MiR-122 and MiR-17 Expressions in Patients with Hepatitis B Liver Fibrosis and Their Predictive Effects on Liver Fibrosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 28(9): 1542-1548 https://doi.org/10.11748/bjmy.issn.1006-1703.2021.09.020

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1138 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉